I tend to agree here cardamine. The thing that scares me though is Patrick Morris at the helm. A very similar investor presentation and offering was done through Euromed Therapeutics and that completely fizzled out.

I actually was in contact with Patrick Morris during that time and the last email I had from him said they were launching in the upcoming weeks. Then radio silence and never heard another thing about Euromed from Doc.

Really hope Kizmet is different and Univec is a major involvement in the investing rounds. There has to be a reason they included Doc on the BOD right??